Inventor · disambiguated record
Walter Won
Also filed as: WON WALTER · WON WALTER S
21 granted patents·8 pending applications·64 citations·filing 2009–2023
92Inventor score
Files withREVOLUTION MEDICINES INC14MERCK SHARP & DOHME10KINESID THERAPEUTICS INC1MAZE THERAPEUTICS INC1MCCORMICK KEVIN D1
Top patents by PatentIndex Score
29 records- 0195US11685749B2C26-linked rapamycin analogs as mTOR inhibitorsREVOLUTION MEDICINES INC·Filed 2020·Granted Jun 27, 2023·5 cites·8 claims
- 0295US10980889B1C40-, C28-, and C-32-linked rapamycin analogs as mTOR inhibitorsREVOLUTION MEDICINES INC·Filed 2020·Granted Apr 20, 2021·8 cites·6 claims
- 0394US12187746B2C26-linked rapamycin analogs as mTOR inhibitorsREVOLUTION MEDICINES INC·Filed 2023·Granted Jan 7, 2025·5 cites·9 claims
- 0494US10590090B22,5-disubstituted 3-methyl pyrazines and 2,5,6-trisubstituted 3-methyl pyrazines as allosteric SHP2 inhibitorsREVOLUTION MEDICINES INC·Filed 2018·Granted Mar 17, 2020·28 cites·50 claims
- 0588US11814367B2Inhibitors of glycogen synthase 1 (GYS1) and methods of use thereofMAZE THERAPEUTICS INC·Filed 2022·Granted Nov 14, 2023·4 cites·41 claims
- 0681US10011615B2Heterobicyclo-substituted [1,2,4]triazolo[1,5-c]quinazolin-5-amine compounds with A2A anatagonist propertiesMERCK SHARP & DOHME·Filed 2017·Granted Jul 3, 2018·3 cites·14 claims
- 0781US8383818B2Functionally selective alpha2C adrenoreceptor agonistsMERCK SHARP & DOHME·Filed 2009·Granted Feb 26, 2013·5 cites·4 claims
- 0875US11739093B2Substituted pyrazolopyrazines, imidazopyrazines and [1,2,4]triazolopyrazines as allosteric SHP2 inhibitorsREVOLUTION MEDICINES INC·Filed 2019·Granted Aug 29, 2023·1 cites·18 claims
- 0973US9676780B2Piperazine-substituted [1,2,4]triazolo[1,5-C]quinazolin-5-amine compounds with A2A antagonist propertiesMERCK SHARP & DOHME·Filed 2013·Granted Jun 13, 2017·2 cites·15 claims
- 1072US10519147B2Diamino-alkylamino-linked arylsulfonamide compounds with selective activity in voltage-gated sodium channelsMERCK SHARP & DOHME·Filed 2016·Granted Dec 31, 2019·1 cites·18 claims
- 1172US10221167B2Hydroxyalkylamine- and hydroxycycloalkylamine-substituted diamine-arylsulfonamide compounds with selective activity in voltage-gated sodium channelsMERCK SHARP & DOHME·Filed 2016·Granted Mar 5, 2019·1 cites·46 claims
- 1271US12365688B2Substituted pyrazolopyrazines, imidazopyrazines and [1,2,4]triazolopyrazines as allosteric SHP2 inhibitorsREVOLUTION MEDICINES INC·Filed 2023·Granted Jul 22, 2025·0 cites·36 claims
- 1370US2024067636A1Pyridine, pyrazine, and triazine compounds as allosteric shp2 inhibitorsREVOLUTION MEDICINES INC·Filed 2023·Application pending·0 cites
- 1470US2024101577A1Polycyclic compounds as allosteric shp2 inhibitorsREVOLUTION MEDICINES INC·Filed 2023·Application pending·0 cites
- 1568US2019336609A1C40-, C28-, and C-32-Linked Rapamycin Analogs as mTOR InhibitorsREVOLUTION MEDICINES INC·Filed 2019·Application pending·0 cites
- 1666US11702411B2Pyridine, pyrazine, and triazine compounds as allosteric SHP2 inhibitorsREVOLUTION MEDICINES INC·Filed 2020·Granted Jul 18, 2023·0 cites·6 claims
- 1766US8324213B2Biaryl-spiroaminooxazoline analogues as alpha 2C adrenergic receptor modulatorsMCCORMICK KEVIN D·Filed 2009·Granted Dec 4, 2012·1 cites·11 claims
- 1864US2023093861A1Rapamycin analogs as mtor inhibitorsREVOLUTION MEDICINES INC·Filed 2022·Application pending·0 cites
- 1961US11661401B22,5-disubstituted 3-methyl pyrazines and 2,5,6-trisubstituted 3-methyl pyrazines as allosteric SHP2 inhibitorsREVOLUTION MEDICINES INC·Filed 2020·Granted May 30, 2023·0 cites·11 claims
- 2060US11673901B2Polycyclic compounds as allosteric SHP2 inhibitorsREVOLUTION MEDICINES INC·Filed 2020·Granted Jun 13, 2023·0 cites·19 claims
- 2160US2021094975A1Rapamycin analogs as mtor inhibitorsREVOLUTION MEDICINES INC·Filed 2019·Application pending·0 cites
- 2255US8569312B2Biaryl-spiroaminooxzaoline analogues as alpha 2C adrenergic receptor modulatorsMERCK SHARP & DOHME·Filed 2013·Granted Oct 29, 2013·0 cites·11 claims
- 2354US8476274B2Biaryl spiroaminooxazoline analogues as Alpha2C adrenergic receptor modulatorsMERCK SHARP & DOHME·Filed 2012·Granted Jul 2, 2013·0 cites·10 claims
- 2453US12246008B24-amino or 4-alkoxy-substituted aryl sulfonamide compounds with selective activity in voltage-gated sodium channelsMERCK SHARP & DOHME LLC·Filed 2019·Granted Mar 11, 2025·0 cites·17 claims
- 2551US2019233406A1HYDROXYALKYLAMINE- and HYDROXYCYCLOALKYLAMINE-SUBSTITUTED DIAMINE-ARYLSULFONAMIDE COMPOUNDS WITH SELECTIVE ACTIVITY IN VOLTAGE-GATED SODIUM CHANNELSMERCK SHARP & DOHME·Filed 2019·Application pending·0 cites
- 2650US2024018105A1Tropolone derivatives and tautomers thereof for iron regulation in animalsKINESID THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 2746US10968210B2Diamino-alkylamino-linked arylsulfonamide compounds with selective activity in voltage-gated sodium channelsMERCK SHARP & DOHME·Filed 2017·Granted Apr 6, 2021·0 cites·19 claims
- 2838US10688082B2Aminopyrazine compounds with A2A antagonist propertiesMERCK SHARP & DOHME·Filed 2016·Granted Jun 23, 2020·0 cites·19 claims
- 2933US2012171126A1NOVEL [3,2-c] HETEROARYL STEROIDS AS GLUCOCORTICOID RECEPTOR AGONISTS COMPOSITIONS AND USES THEREOFPURAKKATTLE BIJU J·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Walter Won files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →